Ticker: Maker of opioid-effect blocker drug Suboxone reaches $102.5M antitrust settlement

The company that makes the opioid addiction treatment drug Suboxone, a branded combo of buprenorphine and naloxone, has agreed to pay $102.5 million to 41 states and the District of Columbia to settle claims that the company engaged in anticompetitive practices, it announced Friday.

The agreement with Indivior, based in North Chesterfield, Virginia, averts a trial that was scheduled to start later this year.

States, including Massachusetts, claimed that the company, previously a subsidiary of Reckitt Benckiser Pharmaceuticals, made modest changes to Suboxone to extend patent protection and keep generic versions of the drug off the market.

The case is distinct from claims brought by governments against other opioid makers, claiming they helped cause or deepen a nationwide overdose crisis. Those have resulted in settlements totaling more than $50 billion so far.

Chase says online banking issue now resolved after bug causes double transactions and fees

Customers of Chase’s online banking services have seen double transactions, fees and payments in their accounts. But by late Friday the bank said it had fixed the glitch.

Numerous Chase customers had posted on social media that their rent or bill payments were taken out of their accounts twice and reported hold times with customer service approaching more than an hour. The New York-based bank is one of the country’s largest financial institutions with millions of online customers.

from Boston Herald https://ift.tt/uE1yxY4